癌症相關科系

腫瘤內科的依據指引

14 個學習主題共依據 14 份臨床指引與文獻。點主題名稱看它的學習重點。

肺癌全身性藥物治療1 份

  1. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines|ESMO|2018
    ESMO的全部指引 · Planchard D, Popat S, Kerr K, et al. · DOI

乳癌全身性藥物治療1 份

  1. SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (UPDATE 2025)|SEOM-GEICAM-SOLTI|2025
    Garcia‑Saenz JA, Lopez-Barajas IB, Echavarria I, et al. · DOI · CC BY-NC-ND 4.0

大腸直腸癌全身性藥物治療1 份

  1. SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer|SEOM-GEMCAD-TTD|2023
    Fernández Montes A, Alonso V, Aranda E, et al. · DOI · CC BY 4.0

肝癌與膽道癌全身性治療1 份

  1. SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients|SEOM-GEMCAD-TTD|2024
    López CL, Calvo M, Cámara JC, et al. · DOI · CC BY 4.0

胃癌與食道癌全身性治療1 份

  1. German, Austrian, and Swiss guidelines for the systemic treatment of gastric cancer|德/奧/瑞學會聯合|2024
    Lordick F, Al-Batran SE, Arnold D, et al. · DOI · CC BY 4.0

胰臟癌全身性治療1 份

  1. SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)|Clinical and Translational Oncology|2021
    Gómez-España MA, Montes AF, Garcia-Carbonero R, et al. · DOI · CC BY 4.0

頭頸癌全身性治療1 份

  1. SEOM–TTCC clinical guidelines for the treatment of head and neck cancer (2025)|Clinical and Translational Oncology|2026
    Arrazubi V, Iglesias L, Oliva M, et al. · DOI · CC BY-NC-ND 4.0

泌尿生殖道癌全身性治療1 份

  1. SEOM–SOGUG clinical guideline for urothelial cancer (2025)|Clinical and Translational Oncology|2025
    Puente J, Rodríguez-Vida A, Sevillano E, et al. · DOI · CC BY-NC-ND 4.0

婦科癌全身性治療1 份

  1. SEOM–GEICO clinical guideline on epithelial ovarian cancer (2023)|Clinical and Translational Oncology|2024
    Perez-Fidalgo JA, Gálvez-Montosa F, Guerra EM, et al. · DOI · CC BY 4.0

標靶治療與生物標記選藥1 份

  1. SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021)|Clinical and Translational Oncology|2022
    de la Haba-Rodriguez J, Lloret FF, Salgado MAV, et al. · DOI · CC BY 4.0

免疫檢查點抑制劑與免疫相關副作用管理1 份

  1. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update|ASCO|2021

荷爾蒙治療1 份

  1. Current Endocrine Therapy in Hormone-Receptor-Positive Breast Cancer|Medicina|2025
    Burciu OM, Merce AG, Cerbu S, et al. · DOI · CC BY 4.0

抗癌藥物不良反應處置1 份

  1. 2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents|MASCC/ESMO|2024
    ESMO的全部指引 · Herrstedt J, Celio L, Hesketh P, et al. · DOI · CC BY 4.0

腫瘤急症1 份

  1. Emergencies in Hematology: Why, When and How I Treat?|J Clin Med|2024
    Duminuco A, Del Fabro V, De Luca P, et al. · DOI · CC BY 4.0

使用 Google 帳號登入,第一次登入時選擇科別即可開始;已經在用?直接登入